Aura Biosciences: Regarding Matters That Are Not Historical Facts Are Forwardlooking Statements Within The Meaning Of The Private Securities Litigation Reform Act Of 1995. Because Such Statements Are Subject To Risks And Uncertainties, Actual Results May Differ Materially From Those Expressed Or Implied By Such Forwardlooking Statements. Such Statements Include, But Are Not Limited To, Statements About The Initiation, Timing, Progress, Results And Cost Of Our Research And Development Programs And Our Current And Future Preclinical Studies And Clinical Trials, Including Statements Regarding The Timing Of Initiation And Completion Of Studies Or Trials And Related Preparatory Work, The Period During Which The Results Of The Trials Will Become Available And Our Research And Development Programs; Our Ability To Successfully Manufacture Our Drug Substances And Product Candidates For Preclinical Use, For Clinical Trials And On A Larger Scale For Commercial Use, If Approved; The Ability And Willingness Of Our Thirdparty Strategic Collaborators To Continue Research And Development Activities Relating To Our Development Candidates And Product Candidates; Our Ability To Commercialize Our Products, If Approved; Our Ability To Obtain Funding For Our Operations Necessary To Complete Further Development And Commercialization Of Our Product Candidates; Our Ability To Obtain And Maintain Regulatory Approval Of Our Product Candidates; The Size And Growth Potential Of The Markets For Our Product Candidates And Our Ability To Serve Those Markets; Our Financial Performance; Our Expected Cash Runway Into The Second Half Of 2026; And The Implementation Of Our Business Model, Including Strategic Plans For Our Business And Product Candidates, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Aura Biosciences Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***